MLICM
ASTH icon

Metropolitan Life Insurance Company (MetLife)’s Astrana Health ASTH Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,277
Closed -$95.6K – 2172
2024
Q1 		$95.6K Sell
2,277
-195
-8% -$7.61K ﹤0.01% 1065
2023
Q4 		$94.7K Hold
2,472
– – ﹤0.01% 1114
2023
Q3 		$76.3K Buy
2,472
+129
+6% +$4.45K ﹤0.01% 1168
2023
Q2 		$74K Buy
2,343
+236
+11% +$8.09K ﹤0.01% 1191
2023
Q1 		$76.8K Sell
2,107
-269
-11% -$9.42K ﹤0.01% 1147
2022
Q4 		$70.3K Hold
2,376
– – ﹤0.01% 1261
2022
Q3 		$92.7K Hold
2,376
– – ﹤0.01% 1063
2022
Q2 		$91.7K Hold
2,376
– – ﹤0.01% 1102
2022
Q1 		$115K Sell
2,376
-7,056
-75% -$364K ﹤0.01% 1106
2021
Q4 		$693K Sell
9,432
-639
-6% -$52.5K 0.01% 1215
2021
Q3 		$917K Hold
10,071
– – 0.01% 1023
2021
Q2 		$633K Buy
10,071
+3,609
+56% +$133K 0.01% 1362
2021
Q1 		$175K Hold
6,462
– – ﹤0.01% 2115
2020
Q4 		$118K Hold
6,462
– – ﹤0.01% 2269
2020
Q3 		$116K Buy
+6,462
New +$111K ﹤0.01% 2139
2019
Q4 		– Sell
-9,431
Closed -$166K – 2565
2019
Q3 		$166K Buy
+9,431
New +$161K ﹤0.01% 2004

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ASTH Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Astrana Health (ASTH) in Q2 2024, closing a stake of 2,277 shares — an estimated $95.6K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ASTH in Q3 2019 and held it in 16 quarters. The position peaked at $917K in Q3 2021. 172 funds tracked by Wall St. Rank hold ASTH as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Astrana Health position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,277 Astrana Health shares in Q2 2024, an estimated $95.6K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Astrana Health in Q3 2019 and held it in 16 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Astrana Health position peaked at $917K in Q3 2021.
  • 172 funds tracked by Wall St. Rank held Astrana Health as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.